Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 2

From BugSigDB
Needs review

Curated date: 2021/01/10

Curator: Mst Afroza Parvin

Revision editor(s): WikiWorks

Source: Supplementary table 3, Supplementary figure 1

Description: A detailed analysis of the MGSs that differed significantly between treatment groups

Abundance in Group 1: decreased abundance in DAV132+moxifloxacin treated group (MXF+DAV132)

NCBI Quality ControlLinks
Bilophila wadsworthia
Bifidobacterium adolescentis
Intestinibacter bartlettii
Bifidobacterium pseudocatenulatum
Catenibacterium
Flavonifractor plautii

Revision editor(s): WikiWorks